{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:02:22Z","timestamp":1793995342069,"version":"4.8.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573616"],"award-info":[{"award-number":["81573616"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81690263"],"award-info":[{"award-number":["81690263"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773911"],"award-info":[{"award-number":["81773911"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jare.2022.09.007","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T04:22:11Z","timestamp":1663993331000},"page":"159-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":178,"special_numbering":"C","title":["Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells"],"prefix":"10.1016","volume":"49","author":[{"given":"Ying","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anni","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jare.2022.09.007_b0005","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.7150\/ijbs.21635","article-title":"Risk factors and preventions of breast cancer","volume":"13","author":"Sun","year":"2017","journal-title":"Int J Biol Sci"},{"issue":"3","key":"10.1016\/j.jare.2022.09.007_b0010","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0360-3016(89)90478-1","article-title":"Radiotherapy, chemotherapy, and tamoxifen as adjuncts to surgery in early breast cancer: a summary of three randomized trials","volume":"16","author":"Rutqvist","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jare.2022.09.007_b0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jtbi.2014.02.025","article-title":"Evolution of acquired resistance to anti-cancer therapy","volume":"355","author":"Foo","year":"2014","journal-title":"J Theor Biol"},{"issue":"8","key":"10.1016\/j.jare.2022.09.007_b0020","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1021\/mp500438x","article-title":"Drug Delivery and Reversal of MDR","volume":"11","author":"Huang","year":"2014","journal-title":"Mol Pharm"},{"issue":"7","key":"10.1016\/j.jare.2022.09.007_b0025","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/s002800051053","article-title":"Multidrug resistance: molecular mechanisms and clinical relevance","volume":"40","author":"Ling","year":"1997","journal-title":"Cancer Chemother Pharmacol"},{"issue":"11","key":"10.1016\/j.jare.2022.09.007_b0030","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/cas.13072","article-title":"Upregulation of programmed cell death ligand 1 promotes resistance response in non-small-cell lung cancer patients treated with neo-adjuvant chemotherapy","volume":"107","author":"Zhang","year":"2016","journal-title":"Cancer Sci"},{"issue":"3","key":"10.1016\/j.jare.2022.09.007_b0035","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/annonc\/mdv615","article-title":"Regulation of PD-L1: a novel role of pro-survival signalling in cancer","volume":"27","author":"Chen","year":"2016","journal-title":"Ann Oncol : Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.jare.2022.09.007_b0040","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.biopha.2018.11.105","article-title":"PD-1\/ PD-L1 blockade as a novel treatment for colorectal cancer","volume":"110","author":"Yaghoubi","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"10.1016\/j.jare.2022.09.007_b0045","first-page":"717","article-title":"The Clinical Relevance of the miR-197\/CKS1B\/STAT3-mediated PD-L1 Network in Chemoresistant Non-small-cell","volume":"23","author":"Fujita","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jare.2022.09.007_b0050","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1242\/jcs.116392","article-title":"The tumor microenvironment at a glance","volume":"125","author":"Balkwill","year":"2012","journal-title":"J Cell Sci"},{"issue":"3","key":"10.1016\/j.jare.2022.09.007_b0055","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/cancers6031670","article-title":"Tumor-associated macrophages as major players in the tumor microenvironment","volume":"6","author":"Chanmee","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.jare.2022.09.007_b0060","doi-asserted-by":"crossref","unstructured":"Yin Y, Yao S, Hu Y, Feng Y, Li M, Bian Z, et al. The immune-microenvironment confers chemoresistance of colorectal cancer through macrophage-derived IL6. Clin Cancer Res; 2017; 23: 7375-87.","DOI":"10.1158\/1078-0432.CCR-17-1283"},{"issue":"24","key":"10.1016\/j.jare.2022.09.007_b0065","doi-asserted-by":"crossref","first-page":"39154","DOI":"10.18632\/oncotarget.16610","article-title":"IL-6R\/STAT3\/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jare.2022.09.007_b0070","doi-asserted-by":"crossref","unstructured":"Dudley AC. Tumor endothelial cells. Cold Spring Harb Perspect Med 2012; 2: 1-18.","DOI":"10.1101\/cshperspect.a006536"},{"issue":"1","key":"10.1016\/j.jare.2022.09.007_b0075","doi-asserted-by":"crossref","DOI":"10.1186\/s40880-017-0219-2","article-title":"Autophagy and multidrug resistance in cancer","volume":"36","author":"Li","year":"2017","journal-title":"Chin J Cancer"},{"issue":"8","key":"10.1016\/j.jare.2022.09.007_b0080","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.biotechadv.2013.06.004","article-title":"Different strategies to overcome multidrug resistance in cancer","volume":"31","author":"Saraswathy","year":"2013","journal-title":"Biotechnol Adv"},{"issue":"8","key":"10.1016\/j.jare.2022.09.007_b0085","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.bcp.2012.01.008","article-title":"Nanoparticle-based combination therapy toward overcoming drug resistance in cancer","volume":"83","author":"Hu","year":"2012","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"10.1016\/j.jare.2022.09.007_b0090","doi-asserted-by":"crossref","first-page":"9518","DOI":"10.1021\/nn405674m","article-title":"Nanoparticles for combination drug therapy","volume":"7","author":"Ma","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jare.2022.09.007_b0095","doi-asserted-by":"crossref","unstructured":"Batist G, Gelmon KA, Chi KN, Miller WH, Jr., Chia SK, Mayer LD, et al. Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors. Clin Cancer Res 2009; 15: 692-700.","DOI":"10.1158\/1078-0432.CCR-08-0515"},{"issue":"12","key":"10.1016\/j.jare.2022.09.007_b0100","doi-asserted-by":"crossref","first-page":"11985","DOI":"10.1007\/s13277-014-2497-5","article-title":"20(s)-ginsenoside Rg3 promotes apoptosis in human ovarian cancer HO-8910 cells through PI3K\/Akt and XIAP pathways","volume":"35","author":"Wang","year":"2014","journal-title":"Tumor Biol"},{"key":"10.1016\/j.jare.2022.09.007_b0105","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3892\/or.2013.2555","article-title":"Ginsenoside Rg3 induces apoptosis in the U87MG human glioblastoma cell line through the MEK signaling pathway and reactive oxygen species","volume":"30","author":"Choi","year":"2013","journal-title":"Oncol Rep"},{"issue":"9","key":"10.1016\/j.jare.2022.09.007_b0110","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1248\/bpb.18.1197","article-title":"Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng","volume":"18","author":"Mochizuki","year":"1995","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jare.2022.09.007_b0115","doi-asserted-by":"crossref","unstructured":"Shan X, Fu YS, Aziz F, Wang XQ, Yan Q, Liu JW. Ginsenoside Rg3 inhibits melanoma cell proliferation through down-regulation of histone deacetylase 3 (HDAC3) and increase of p53 acetylation. PLoS One 2014; 9: e115401.","DOI":"10.1371\/journal.pone.0115401"},{"key":"10.1016\/j.jare.2022.09.007_b0120","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bcp.2006.04.034","article-title":"The angiosuppressive effects of 20(R)- ginsenoside Rg","volume":"72","author":"Yue","year":"2006","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.jare.2022.09.007_b0125","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1248\/bpb.17.635","article-title":"Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2","volume":"17","author":"Sato","year":"1994","journal-title":"Biological Pharmaceutical Bulletin"},{"key":"10.1016\/j.jare.2022.09.007_b0130","first-page":"4376","article-title":"Treatment with 20(S)-ginsenoside Rg3 reverses multidrug resistance in A549\/DDP xenograft tumors","volume":"15","author":"Liu","year":"2018","journal-title":"Oncol Lett"},{"issue":"2","key":"10.1016\/j.jare.2022.09.007_b0135","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12272-001-1137-y","article-title":"Selective toxicity of ginsenoside Rg3 on multidrug resistant cells by membrane fluidity modulation","volume":"31","author":"Kwon","year":"2008","journal-title":"Arch Pharm Res"},{"issue":"1","key":"10.1016\/j.jare.2022.09.007_b0140","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/cas.13881","article-title":"20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma","volume":"110","author":"Chen","year":"2019","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jare.2022.09.007_b0145","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0006-2952(02)01446-6","article-title":"Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg","volume":"65","author":"Kim","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jare.2022.09.007_b0150","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.biopha.2017.09.129","article-title":"Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immune","volume":"96","author":"Jiang","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.jare.2022.09.007_b0155","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jgr.2016.12.012","article-title":"Ginsenoside Rg3promotes inflammation resolution through M2 macrophage polarization","volume":"42","author":"Kang","year":"2018","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jare.2022.09.007_b0160","first-page":"299","article-title":"Mechanism of Shenyi Capsule concomitant with endostar and chemotherapy on the growth and apoptosis of MCF-7 breast cancer cells","volume":"2","author":"Shao","year":"2014","journal-title":"J Int Translat Med"},{"key":"10.1016\/j.jare.2022.09.007_b0165","unstructured":"Jiwei L, Liangxin S, Yi Z, al e. Clinical Phase II Study on Immunoimprovement of Patients with Breast Cancer Treated by Shenyi Capsule. Chin J Clin Oncol 2000; 27: 534-6."},{"key":"10.1016\/j.jare.2022.09.007_b0170","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3736\/jcim20091105","article-title":"Efficacy of Shenyi Capsule combined with gemcitabine plus cisplatin in treatment of advanced esophageal cancer:a randomized controlled trial","volume":"7","author":"Huang","year":"2009","journal-title":"J Chin Integrat Med"},{"issue":"2","key":"10.1016\/j.jare.2022.09.007_b0175","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0006-2952(99)00316-0","article-title":"Biomimetic transport and rational drug delivery","volume":"59","author":"Ranney","year":"2000","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.jare.2022.09.007_b0180","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jconrel.2009.09.020","article-title":"Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals","volume":"141","author":"Ying","year":"2010","journal-title":"J Controlled Release Off J Controlled Release Soc"},{"issue":"10","key":"10.1016\/j.jare.2022.09.007_b0185","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1002\/1097-0142(19931115)72:10<2979::AID-CNCR2820721020>3.0.CO;2-X","article-title":"Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study","volume":"72","author":"Brown","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.jare.2022.09.007_b0190","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/138920207780368187","article-title":"Functional properties and genomics of glucose transporters","volume":"8","author":"Zhao","year":"2007","journal-title":"Curr Genomics"},{"issue":"1","key":"10.1016\/j.jare.2022.09.007_b0195","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0006-291X(05)81022-8","article-title":"Erythrocyte\/HepG2-type glucose transporter is concentrated in cells of blood-tissue barriers","volume":"173","author":"Takata","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.jare.2022.09.007_b0200","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/09687680110090456","article-title":"The extended GLUT-family of sugar\/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members","volume":"18","author":"Joost","year":"2001","journal-title":"Mol Membr Biol"},{"issue":"1-3","key":"10.1016\/j.jare.2022.09.007_b0205","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0169-409X(95)00007-T","article-title":"Vector-mediated peptide drug delivery to the brain","volume":"15","author":"Pardridge","year":"1995","journal-title":"Adv Drug Deliv Rev"},{"issue":"15","key":"10.1016\/j.jare.2022.09.007_b0210","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.7150\/thno.34953","article-title":"Novel ginsenoside-based multifunctional liposomal delivery system for combination therapy of gastric cancer","volume":"9","author":"Hong","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jare.2022.09.007_b0215","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jconrel.2020.12.036","article-title":"Multifunctional ginsenoside Rg3-based liposomes for glioma targeting therapy","volume":"330","author":"Zhu","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.jare.2022.09.007_b0220","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.2147\/IJN.S113723","article-title":"Development of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation","volume":"11","author":"Hong","year":"2016","journal-title":"Int J Nanomed"},{"issue":"8","key":"10.1016\/j.jare.2022.09.007_b0225","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1021\/mp400154a","article-title":"Determination of drug release kinetics from nanoparticles: overcoming pitfalls of the dynamic dialysis method","volume":"10","author":"Modi","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.jare.2022.09.007_b0230","first-page":"11","volume":"83","author":"The isolation and characterization of murine macrophages","year":"2015","journal-title":"Current Protocols in Immunology"},{"issue":"3","key":"10.1016\/j.jare.2022.09.007_b0235","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1021\/bc060184s","article-title":"Fluorescent fructose derivatives for imaging breast cancer cells","volume":"18","author":"Levi","year":"2007","journal-title":"Bioconjug Chem"},{"issue":"1-3","key":"10.1016\/j.jare.2022.09.007_b0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0169-409X(95)00002-O","article-title":"Preface: Overview of brain drug delivery","volume":"15","author":"Pardridge","year":"1995","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"10.1016\/j.jare.2022.09.007_b0245","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1182\/blood.V84.5.1415.bloodjournal8451415","article-title":"Van Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis","volume":"84","author":"Koopman","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jare.2022.09.007_b0250","first-page":"31","article-title":"Studies of 20(R)-ginsenoside Rg3 on reversal multidrug resistance (MDR) and induction of apoptosis in K562\/ADM cell line","volume":"8","author":"Gao","year":"2002","journal-title":"Progr Anatomical Sci"},{"issue":"11","key":"10.1016\/j.jare.2022.09.007_b0255","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol"},{"issue":"4","key":"10.1016\/j.jare.2022.09.007_b0260","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejps.2009.08.009","article-title":"Paclitaxel and immune system","volume":"38","author":"Javeed","year":"2009","journal-title":"Eur J Pharm"},{"key":"10.1016\/j.jare.2022.09.007_b0265","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jchromb.2017.09.002","article-title":"Characterization of the changes in eicosanoid profiles of activated macrophages treated with 20(S)-ginsenoside Rg3","volume":"1065-1066","author":"Lee","year":"2017","journal-title":"J Chromatogr B Analyt Technol Biomed Life"},{"issue":"3","key":"10.1016\/j.jare.2022.09.007_b0270","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/cbdd.12893","article-title":"Breast tumor stroma: A driving force in the development of resistance to therapies","volume":"89","author":"Majidinia","year":"2017","journal-title":"Chem Biol Drug Des"},{"issue":"8","key":"10.1016\/j.jare.2022.09.007_b0275","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.3390\/ijms13089545","article-title":"Implication of tumor microenvironment in chemoresistance: tumor-associated stromal cells protect tumor cells from cell death","volume":"13","author":"Castells","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2022.09.007_b0280","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.biocel.2019.02.002","article-title":"Extracellular matrix-mediated regulation of cancer stem cells and chemoresistance","volume":"109","author":"Brown","year":"2019","journal-title":"Int J Biochem Cell Biol"},{"issue":"7","key":"10.1016\/j.jare.2022.09.007_b0285","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.3390\/ijms18071586","article-title":"The role of tumor microenvironment in chemoresistance: to survive, keep your enemies closer","volume":"18","author":"Senthebane","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2022.09.007_b0290","first-page":"14904","article-title":"A convenient method for quantifying collagen fibers in atherosclerotic lesions by ImageJ software","volume":"10","author":"Chen","year":"2017","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.jare.2022.09.007_b0295","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1084\/jem.161.3.475","article-title":"Quantitative analysis of total macrophage content in adult mouse tissues. Immunochemical studies with monoclonal antibody F4\/80","volume":"161","author":"Lee","year":"1985","journal-title":"J Exp Med"},{"key":"10.1016\/j.jare.2022.09.007_b0300","first-page":"263","article-title":"Much more than M1 and M2 macrophages, there are also CD169(+) and TCR(+) macrophages","volume":"6","author":"Ch\u00e1vez Gal\u00e1n","year":"2015","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jare.2022.09.007_b0305","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.jare.2022.09.007_b0310","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nri1995","article-title":"Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment","volume":"7","author":"Yu","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.jare.2022.09.007_b0315","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tips.2015.10.001","article-title":"Feedback activation of STAT3 as a cancer drug-resistance mechanism","volume":"37","author":"Zhao","year":"2016","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jare.2022.09.007_b0320","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fonc.2018.00049","article-title":"Targeting macrophages in cancer: from bench to bedside","volume":"8","author":"Poh","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.jare.2022.09.007_b0325","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3892\/ijo.2014.2259","article-title":"The IL-6\/JAK\/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer","volume":"44","author":"Wang","year":"2014","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jare.2022.09.007_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112995","article-title":"Novel application of rhein and its prodrug diacerein for reversing cancer-related multidrug resistance through the dual inhibition of P-glycoprotein efflux and STAT3-mediated P-glycoprotein expression[J]","volume":"150","author":"Teng","year":"2022","journal-title":"Biomed Pharmacother"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123222002090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123222002090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:55:43Z","timestamp":1761857743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123222002090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":66,"alternative-id":["S2090123222002090"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2022.09.007","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2022.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}